Abstract: Systems, methods, and apparatuses for generating and releasing iodine are described. Some embodiments may include a dressing member including a plurality of iodine-forming reagents and a water-swellable material. In some embodiments, the dressing member may include water-swellable fibers. The water-swellable fibers may each include a water-swellable material in which iodine-forming reagents are dispersed. As liquid comes into contact with and is absorbed by the water-swellable material, the iodine-forming reagents may come into contact with each other, causing an iodine-forming reaction to occur, producing iodine.

Abstract: Disclosed embodiments relate to devices and systems for providing negative-pressure therapy, instillation, and/or pressure-sensing at a tissue site, and to methods of manufacturing such devices and systems. In some embodiments, a fluid bridge may comprise a first layer of foam with a plurality of supports extending from at least an inner surface, and a second layer. The first and second layers may be coupled together around the perimeter to form one or more enclosed fluid pathways, for example extending from a port to an aperture. In some embodiments, at least the first layer may be formed of closed-cell foam.

Abstract: A dressing for treating a tissue site may include a base layer, a sealing member, a first and a second wicking layer, and an absorbent layer. The base layer may have a periphery surrounding a central portion and a plurality of apertures disposed through the periphery and the central portion. The apertures in the periphery may be larger than the apertures in the central portion. The sealing member and the base layer may define an enclosure. The first and the second wicking layer may each be disposed in the enclosure with the absorbent layer positioned between the first and the second wicking layer. Other dressings, systems, and methods are disclosed.

Abstract: In some examples, provided is a fluid blockage device for use with a reduced-pressure source for treating a tissue site with reduced pressure. The fluid blockage device may be configured to preclude fluid communication through a port fluidly coupled to the reduced-pressure source when the fluid blockage device contacts a liquid. Other devices, systems, and methods are disclosed.

Abstract: In one example embodiment, an apparatus may include a panel with integrated fluid channels, wherein the panel and the fluid channel consist only of surfaces that can be manufactured with a straight-pull mold. A port may also be integrated into the panel to facilitate coupling the fluid channel to pneumatic components in an assembly. A seal may be secured to the panel over the fluid channel to form an integrated fluid conductor. The seal is preferably an adhesive label that can also be used for product labeling. Such an apparatus may be used in a control unit of a therapy system, employing several integrated fluid conductors. A method of manufacturing may include molding a panel, wherein the mold forms a channel integral to the panel. The panel and the channel preferably consist of surfaces that can be molded with a straight-pull mold.

Abstract: A fluid delivery system, method, and apparatus for providing instillation therapy with a negative-pressure source is described. The apparatus includes a housing having an ambient chamber and a negative-pressure chamber fluidly isolated from each other. The apparatus also includes a moveable barrier disposed in the housing between the ambient chamber and the negative-pressure chamber. The moveable barrier is operable to move between a charge position and a discharge position in response to negative pressure. A fluid source is disposed in the negative-pressure chamber and is collapsible in response to movement of the moveable barrier to the discharge position. The apparatus also includes a fluid outlet in fluid communication with the fluid source, a negative-pressure port in fluid communication with the negative-pressure chamber and configured to be coupled to a negative-pressure source, and a vent formed in the housing and fluidly coupled to the ambient chamber.

Abstract: As an example, in some embodiments is a dressing that may comprise a manifold, a bioresorbable component, and a degradation-modulating component. The degradation-modulating component may cover two or more surfaces of the bioresorbable component. The degradation-modulating component may be further configured to modulate degradation of the bioresorbable component.

Abstract: Dressings for treating a tissue site with instillation therapy are disclosed, which may include a dressing having a first layer comprising a polymer film having a plurality of fluid restrictions through the polymer film and a second layer comprising a polymer having a plurality of apertures. The second layer is adjacent to the first layer. The dressing may include an adhesive layer on at least a portion of the first layer. Further, the dressing may include a third layer on the adhesive layer, the third layer being at least partially removable from the adhesive layer so as to expose a portion of the adhesive.

Abstract: Systems, methods, and apparatuses for irrigating a tissue site are described. The system can include a tissue interface and a sealing member configured to be placed over the tissue site to form a sealed space, and a negative-pressure source fluidly coupled to the sealed space. The system includes an irrigation valve having a housing, a piston disposed in the housing, a fluid inlet to fluidly couple a fluid inlet chamber to a fluid source, and a fluid outlet to fluidly couple a fluid outlet chamber to the sealed space. A piston passage extends through the piston and fluidly couples the fluid inlet chamber and the fluid outlet chamber, and a biasing member is coupled to the piston to bias the irrigation valve to a closed position. The negative-pressure source is configured to move the piston between the closed position and an open position to draw fluid to the sealed space.

Abstract: A tissue interface for treating a tissue site and systems and methods of manufacturing the same are described. The tissue interface can include a plurality of shapes and a plurality of ribs. Each rib of the plurality of ribs can have a first end coupled to a respective shape of the plurality of shapes and a second end coupled to at least one other rib of the plurality of ribs. The tissue interface can also include a sheet of felted open-cell foam and a plurality of holes formed in the sheet. Each hole can extend through the sheet. Each hole can have a first end and a second end joined by a gauge section. The first end and the second end can form shoulders that are wider than the gauge section.

Abstract: A treatment system for applying negative pressure to a tissue site in conjunction with a venting or purging capability. In some embodiments, the treatment system may include a reduced-pressure source, an inline storage pouch, a purge chamber, and a dressing. Reduced-pressure may be supplied to the inline storage pouch and the dressing, while the purge chamber may provide a ventilation opening to the atmosphere.

Abstract: Disclosed embodiments may relate to negative-pressure therapy, which may collect exudate from a tissue site. In some embodiments, a multi-canister module may allow a single negative-pressure source to draw exudate into two or more canisters. In some embodiments, pressure sensing may take place alongside negative-pressure treatment. In some embodiments, the multi-canister module may be configured to allow for one of the canisters to be changed without interrupting negative-pressure therapy.

Abstract: In some embodiments, a dressing may comprise a treatment device configured with a central hub and a plurality of legs extending out from the central hub. In some embodiments, the central hub and legs may jointly comprise a treatment manifold configured to minimize tissue in-growth. For example, the treatment manifold may comprise closed-cell foam. In some embodiments, the treatment manifold may be unencapsulated. For example, a single film layer may be attached to a first surface of the treatment manifold, while an opposite surface of the manifold may be exposed and/or uncovered. Other apparatus, dressings, systems, and methods are also disclosed.

Abstract: An indicator, wound dressing system, and negative pressure wound treatment kit configured to provide near real-time, dynamic indication of the fluid status (e.g., fill level, fluid absorbency capacity) of an article is described according to various embodiments. The indicator for detecting a fluid status of a wound dressing may include at least (i) a top side comprising PVDF and one or more markings configured to show fluid levels (ii) a bottom side comprising a pattern-printed adhesive, and (iii) a buffer layer, wherein the buffer layer has a top side comprising a polyurethane film and a bottom side comprising a film retention adhesive. Methods of using the indicator, wound dressing system, and kit are also provided herein.

Abstract: Provided herein is a system and method for mitigating premature light deactivation of light deactivated adhesive drapes. One aspect provides a system comprising a drape, a photosensitive adhesive layer, and a release agent, where the system is adapted to be coupled to a tissue site and released therefrom upon or after exposure to an external stimulus such as certain wavelengths of light. The system may have a filter layer to prevent the photosensitive adhesive from being exposed to deactivation wavelengths prematurely. The filter layer may be printed directly onto the drape and may be removable after exposure to a solvent, such as isopropyl alcohol (IPA). The filter layer may also be a filter adhesive layer. Another aspect provides a method for application and removal of a drape using by removing one or more of the filter layer and/or the filter adhesive layer and applying light to the drape to deactivate the photosensitive adhesive layer and promote easy, clean, and less painful removal of the drape.

Abstract: A dressing may comprise a manifold having a first planar surface and a second planar surface opposite the first planar surface, and a first layer adjacent to the first planar surface and a second layer adjacent to the second planar surface. The first layer and the second layer may be laminated to the first planar surface and the second planar surface, respectively. Pressure-responsive fluid restrictions through at least one of the first layer and the second layer may be adjacent to the manifold. The first layer and the second layer may also form a sleeve or an envelope around the manifold in some embodiments. At least one of the first layer and the second layer may be configured to be disposed between the manifold and a tissue site in use. In some examples, the dressing may have a smooth or matte surface configured to contact a tissue site.

Abstract: A dressing for treating a tissue site may include a base layer, a sealing member, a first and a second wicking layer, and an absorbent layer. The base layer may have a periphery surrounding a central portion and a plurality of apertures disposed through the periphery and the central portion. At least one of the apertures in the periphery may be positioned at an edge of the periphery, and may have an interior exposed at the edge. The sealing member and the base layer may define an enclosure. The first and the second wicking layer may each be disposed in the enclosure with the absorbent layer positioned between the first and the second wicking layer. Other dressings, systems, and methods are disclosed.

Abstract: In some illustrative examples, a bridge suitable for treating a tissue site may include a bridge sealing member and one or more bridge wicking layers. The bridge sealing member may extend along a length of the bridge, and may define an internal passageway in fluid communication between a receiving end of the bridge and a transmitting end of the bridge. The one or more bridge wicking layers may be disposed within the internal passageway of the bridge sealing member. Other apparatus, systems, and methods are disclosed.

Abstract: A system and apparatus for promoting perfusion at a tissue site containing a sprain by applying a vacuum to intact skin extending over or surrounding the tissue site. The system and apparatus comprise a manifold formed from a porous material and configured to be disposed proximate the intact skin for distributing vacuum to the intact skin, and a sleeve adapted to cover the manifold and form a chamber containing the manifold to seal the manifold within the chamber between the sleeve and the intact skin. The system and apparatus further comprise a fluid coupling member adapted to deliver vacuum to the manifold for distribution to the intact skin. A method for applying vacuum to the intact skin of a tissue site is also disclosed and described herein.

Abstract: A sampling interface may comprise an inlet port, an outlet port, and a sampling chamber between the inlet port and the outlet port. The apparatus may also comprise a sampling port and at least one split seal between the sampling port and the sampling chamber. The split seal may comprise a first sealing member and a second sealing member that converge to a sealing line. The apparatus may additionally include at least one fluid collection channel disposed interior to the split seal. A lateral flow strip for sampling fluid removed from a tissue site may comprise an acquisition surface and a migration medium fluidly coupled to the acquisition surface. At least one test medium may be fluidly coupled to the migration medium, and a liquid-impermeable cover may enclose the migration medium and the test medium. The acquisition surface is preferably not enclosed.